[2]
Hatano T,Okuma Y,Iijima M,Fujishima K,Goto K,Mizuno Y, Cervical dystonia in dentatorubral-pallidoluysian atrophy. Acta neurologica Scandinavica. 2003 Oct; [PubMed PMID: 12956864]
[4]
Lindsay E,Storey E, Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature. Brain sciences. 2017 Jul 14; [PubMed PMID: 28708110]
[5]
Adachi N,Arima K,Asada T,Kato M,Minami N,Goto Yi,Onuma T,Ikeuchi T,Tsuji S,Hayashi M,Fukutani Y, Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis. The Journal of neuropsychiatry and clinical neurosciences. 2001 Spring; [PubMed PMID: 11449034]
[6]
Ito D,Yamada M,Kawai M,Usui T,Hamada J,Fukuuchi Y, Corneal endothelial degeneration in dentatorubral-pallidoluysian atrophy. Archives of neurology. 2002 Feb; [PubMed PMID: 11843701]
[7]
Ohizumi H,Okuma Y,Fukae J,Fujishima K,Goto K,Mizuno Y, Head tremor in dentatorubral-pallidoluysian atrophy. Acta neurologica Scandinavica. 2002 Nov; [PubMed PMID: 12371928]
[8]
Silver MR,Sethi KD,Mehta SH,Nichols FT,Morgan JC, Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA). BMC neurology. 2015 Dec 18; [PubMed PMID: 26679169]
[9]
TITICA J,VAN BOGAERT L, Heredo-degenerative hemiballismus; a contribution to the question of primary atrophy of the corpus luysii. Brain : a journal of neurology. 1946 Dec [PubMed PMID: 20287644]
[10]
SMITH JK,GONDA VE,MALAMUD N, Unusual form of cerebellar ataxia; combined dentato-rubral and pallido-Luysian degeneration. Neurology. 1958 Mar [PubMed PMID: 13517487]
[11]
Nagafuchi S,Yanagisawa H,Sato K,Shirayama T,Ohsaki E,Bundo M,Takeda T,Tadokoro K,Kondo I,Murayama N, Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature genetics. 1994 Jan; [PubMed PMID: 8136826]
[12]
Bidollari E,Rotundo G,Altieri F,Amicucci M,Wiquel D,Ferrari D,Goldoni M,Bernardini L,Consoli F,De Luca A,Fanelli S,Lamorte G,D'Agruma L,Vescovi AL,Squitieri F,Rosati J, Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA). Stem cell research. 2019 Oct [PubMed PMID: 31493762]
[13]
Hasegawa A,Ikeuchi T,Koike R,Matsubara N,Tsuchiya M,Nozaki H,Homma A,Idezuka J,Nishizawa M,Onodera O, Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length. Movement disorders : official journal of the Movement Disorder Society. 2010 Aug 15; [PubMed PMID: 20589872]
[14]
Maruyama S,Saito Y,Nakagawa E,Saito T,Komaki H,Sugai K,Sasaki M,Kumada S,Saito Y,Tanaka H,Minami N,Goto Y, Importance of CAG repeat length in childhood-onset dentatorubral-pallidoluysian atrophy. Journal of neurology. 2012 Nov; [PubMed PMID: 22527233]
[15]
Carroll LS,Massey TH,Wardle M,Peall KJ, Dentatorubral-pallidoluysian Atrophy: An Update. Tremor and other hyperkinetic movements (New York, N.Y.). 2018; [PubMed PMID: 30410817]
[16]
Yamada M, Dentatorubral-pallidoluysian atrophy (DRPLA): The 50th Anniversary of Japanese Society of Neuropathology. Neuropathology : official journal of the Japanese Society of Neuropathology. 2010 Oct; [PubMed PMID: 20500452]
[17]
Wardle M,Morris HR,Robertson NP, Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review. Movement disorders : official journal of the Movement Disorder Society. 2009 Aug 15; [PubMed PMID: 19514013]
[18]
Tsuji S,Onodera O,Goto J,Nishizawa M, Sporadic ataxias in Japan--a population-based epidemiological study. Cerebellum (London, England). 2008; [PubMed PMID: 18418674]
[19]
Natural incidence of stomach worms in domestic swine from Georgia & Wisconsin., Peterson PM,Todd AC,, Veterinary medicine, small animal clinician : VM, SAC, 1977 Nov [PubMed PMID: 11709002]
[20]
Coutinho P,Ruano L,Loureiro JL,Cruz VT,Barros J,Tuna A,Barbot C,Guimarães J,Alonso I,Silveira I,Sequeiros J,Marques Neves J,Serrano P,Silva MC, Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA neurology. 2013 Jun; [PubMed PMID: 23609960]
[21]
Erichsen AK,Koht J,Stray-Pedersen A,Abdelnoor M,Tallaksen CM, Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain : a journal of neurology. 2009 Jun; [PubMed PMID: 19339254]
[22]
Yiş U,Dirik E,Gündoğdu-Eken A,Başak AN, Dentatorubral pallidoluysian atrophy in a Turkish family. The Turkish journal of pediatrics. 2009 Nov-Dec; [PubMed PMID: 20196398]
[23]
Destée A,Delalande I,Vuillaume I,Schraen-Maschke S,Defebvre L,Sablonnière B, The first identified French family with dentatorubral-pallidoluysian atrophy. Movement disorders : official journal of the Movement Disorder Society. 2000 Sep; [PubMed PMID: 11009212]
[24]
Martins S,Matamá T,Guimarães L,Vale J,Guimarães J,Ramos L,Coutinho P,Sequeiros J,Silveira I, Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin. European journal of human genetics : EJHG. 2003 Oct [PubMed PMID: 14512972]
[26]
Charroux B,Fanto M, The fine line between waste disposal and recycling: DRPLA fly models illustrate the importance of completing the autophagy cycle for rescuing neurodegeneration. Autophagy. 2010 Jul; [PubMed PMID: 20543566]
[27]
Stevanin G,Giunti P,Belal GD,Dürr A,Ruberg M,Wood N,Brice A, De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Human molecular genetics. 1998 Oct; [PubMed PMID: 9736784]
[28]
Keo A,Aziz NA,Dzyubachyk O,van der Grond J,van Roon-Mom WMC,Lelieveldt BPF,Reinders MJT,Mahfouz A, Co-expression Patterns between {i}ATN1{/i} and {i}ATXN2{/i} Coincide with Brain Regions Affected in Huntington's Disease. Frontiers in molecular neuroscience. 2017; [PubMed PMID: 29249939]
[29]
Zhang F,Xu D,Yuan L,Sun Y,Xu Z, Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance. Nature communications. 2014 Dec 18; [PubMed PMID: 25519973]
[30]
Suzuki Y,Nakayama K,Hashimoto N,Yazawa I, Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy. The FEBS journal. 2010 Dec; [PubMed PMID: 20977674]
[31]
Arrasate M,Mitra S,Schweitzer ES,Segal MR,Finkbeiner S, Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004 Oct 14; [PubMed PMID: 15483602]
[32]
Miller J,Arrasate M,Shaby BA,Mitra S,Masliah E,Finkbeiner S, Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010 Aug 4; [PubMed PMID: 20685997]
[33]
Suzuki K,Sato T,Yamada M,Takahashi H,Tsuji S, DRPLA: recent advances in research using transgenic mouse models. Methods in molecular biology (Clifton, N.J.). 2013; [PubMed PMID: 23754232]
[34]
Yamada M,Shimohata M,Sato T,Tsuji S,Takahashi H, Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy. Neuropathology : official journal of the Japanese Society of Neuropathology. 2006 Aug; [PubMed PMID: 16961072]
[35]
Dunn P,Albury CL,Maksemous N,Benton MC,Sutherland HG,Smith RA,Haupt LM,Griffiths LR, Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes. Frontiers in genetics. 2018; [PubMed PMID: 29467791]
[36]
Jiang T,Tan MS,Tan L,Yu JT, Application of next-generation sequencing technologies in Neurology. Annals of translational medicine. 2014 Dec; [PubMed PMID: 25568878]
[37]
Egawa K,Takahashi Y,Kubota Y,Kubota H,Inoue Y,Fujiwara T,Onodera O, Electroclinical features of epilepsy in patients with juvenile type dentatorubral-pallidoluysian atrophy. Epilepsia. 2008 Dec; [PubMed PMID: 18616556]
[38]
Kobayashi K,Takeuchi A,Oka M,Akiyama M,Ohtsuka Y, Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam. Brain [PubMed PMID: 21889282]
[39]
Sugiyama A,Sato N,Nakata Y,Kimura Y,Enokizono M,Maekawa T,Kondo M,Takahashi Y,Kuwabara S,Matsuda H, Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy. Journal of neurology. 2018 Feb; [PubMed PMID: 29236168]
[40]
Yoon WT,Youn J,Cho JW, Is cerebral white matter involvement helpful in the diagnosis of dentatorubral-pallidoluysian atrophy? Journal of neurology. 2012 Aug; [PubMed PMID: 22286658]
[41]
Sunami Y,Koide R,Arai N,Yamada M,Mizutani T,Oyanagi K, Radiologic and neuropathologic findings in patients in a family with dentatorubral-pallidoluysian atrophy. AJNR. American journal of neuroradiology. 2011 Jan; [PubMed PMID: 20966051]
[42]
Muñoz E,Campdelacreu J,Ferrer I,Rey MJ,Cardozo A,Gómez B,Tolosa E, Severe cerebral white matter involvement in a case of dentatorubropallidoluysian atrophy studied at autopsy. Archives of neurology. 2004 Jun; [PubMed PMID: 15210537]
[43]
Simpson M,Smith A,Kent H,Roxburgh R, Neurological picture. Distinctive MRI abnormalities in a man with dentatorubral-pallidoluysian atrophy. Journal of neurology, neurosurgery, and psychiatry. 2012 May; [PubMed PMID: 22362920]
[44]
de Souza PV,Batistella GN,Pinto WB,Oliveira AS, Teaching NeuroImages: Leukodystrophy and progressive myoclonic epilepsy disclosing DRPLA. Neurology. 2016 Feb 9; [PubMed PMID: 26857957]
[45]
Nagai S,Saito Y,Endo Y,Saito T,Sugai K,Ishiyama A,Komaki H,Nakagawa E,Sasaki M,Ito K,Saito Y,Sukigara S,Ito M,Goto Y,Ito S,Matsuoka K, Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs. Journal of neurology. 2013 May; [PubMed PMID: 23263592]
[46]
Shiraishi H,Egawa K,Ito T,Kawano O,Asahina N,Kohsaka S, Efficacy of perampanel for controlling seizures and improving neurological dysfunction in a patient with dentatorubral-pallidoluysian atrophy (DRPLA). Epilepsy [PubMed PMID: 28856097]
[47]
Hamada S,Shimakawa S,Satomura S,Naito E,Hashimoto T, [Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)]. No to hattatsu = Brain and development. 2014 Nov; [PubMed PMID: 25558587]
[48]
Gazulla J,Errea JM,Benavente I,Tordesillas CJ, Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study. European neurology. 2004; [PubMed PMID: 15218338]
[49]
van de Warrenburg BP,van Gaalen J,Boesch S,Burgunder JM,Dürr A,Giunti P,Klockgether T,Mariotti C,Pandolfo M,Riess O, EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. European journal of neurology. 2014 Apr; [PubMed PMID: 24418350]
[50]
Ristori G,Romano S,Visconti A,Cannoni S,Spadaro M,Frontali M,Pontieri FE,Vanacore N,Salvetti M, Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology. 2010 Mar 9; [PubMed PMID: 20211908]
[51]
Romano S,Coarelli G,Marcotulli C,Leonardi L,Piccolo F,Spadaro M,Frontali M,Ferraldeschi M,Vulpiani MC,Ponzelli F,Salvetti M,Orzi F,Petrucci A,Vanacore N,Casali C,Ristori G, Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 2015 Oct; [PubMed PMID: 26321318]
[52]
Botez MI,Botez-Marquard T,Elie R,Pedraza OL,Goyette K,Lalonde R, Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study. Journal of neurology, neurosurgery, and psychiatry. 1996 Sep; [PubMed PMID: 8795596]
[53]
Kotowska-Zimmer A,Ostrovska Y,Olejniczak M, Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression. Molecular therapy. Nucleic acids. 2020 Mar 6; [PubMed PMID: 31927329]
[54]
Yang S,Chang R,Yang H,Zhao T,Hong Y,Kong HE,Sun X,Qin Z,Jin P,Li S,Li XJ, CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease. The Journal of clinical investigation. 2017 Jun 30; [PubMed PMID: 28628038]
[55]
Drouet V,Ruiz M,Zala D,Feyeux M,Auregan G,Cambon K,Troquier L,Carpentier J,Aubert S,Merienne N,Bourgois-Rocha F,Hassig R,Rey M,Dufour N,Saudou F,Perrier AL,Hantraye P,Déglon N, Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells. PloS one. 2014; [PubMed PMID: 24926995]
[56]
Verma AK,Khan E,Bhagwat SR,Kumar A, Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders. Molecular neurobiology. 2020 Jan; [PubMed PMID: 31399954]
[57]
Kobayashi J,Nagao M,Kawata A,Matsubara S, A case of late adult-onset dentatorubral-pallidoluysian atrophy mimicking central pontine myelinolysis. Journal of neurology. 2009 Aug; [PubMed PMID: 19390768]
[58]
Ilg W,Synofzik M,Brötz D,Burkard S,Giese MA,Schöls L, Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology. 2009 Dec 1; [PubMed PMID: 19864636]
[59]
Fonteyn EM,Keus SH,Verstappen CC,van de Warrenburg BP, Physiotherapy in degenerative cerebellar ataxias: utilisation, patient satisfaction, and professional expertise. Cerebellum (London, England). 2013 Dec; [PubMed PMID: 23733611]
[60]
Fonteyn EM,Keus SH,Verstappen CC,Schöls L,de Groot IJ,van de Warrenburg BP, The effectiveness of allied health care in patients with ataxia: a systematic review. Journal of neurology. 2014 Feb; [PubMed PMID: 23589192]
[61]
Hartley H,Cassidy E,Bunn L,Kumar R,Pizer B,Lane S,Carter B, Exercise and Physical Therapy Interventions for Children with Ataxia: A Systematic Review. Cerebellum (London, England). 2019 Oct; [PubMed PMID: 31392562]
[62]
Miyai I,Ito M,Hattori N,Mihara M,Hatakenaka M,Yagura H,Sobue G,Nishizawa M, Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabilitation and neural repair. 2012 Jun; [PubMed PMID: 22140200]
[63]
Ilg W,Bastian AJ,Boesch S,Burciu RG,Celnik P,Claaßen J,Feil K,Kalla R,Miyai I,Nachbauer W,Schöls L,Strupp M,Synofzik M,Teufel J,Timmann D, Consensus paper: management of degenerative cerebellar disorders. Cerebellum (London, England). 2014 Apr; [PubMed PMID: 24222635]